Verified
Sarepta Therapeutics
Pharmaceuticals
Founded: 2002
Headquarters: 215 First Street, Cambridge, Massachusetts 02142, USA
Overview
Location
Massachusetts, United States
Headquarter
215 First Street, Cambridge, Massachusetts 02142, USA
Contact Number
6172744000
Industry
Pharmaceuticals
Contact Email
Not Available
Company Type
Public Company
Website
Founded
2002
CEO
Douglas S. Ingram
Codes
SIC Code 28,283 | NAICS Code 32,325
Annual Revenue
1.25 Billion USD
Total Funding
$2.8B
Recent Funding Amount
$250M
No of Funding Rounds
17
Founders
Louis K. Chang
Company Overview
Established in 1980, Sarepta Therapeutics conducts research on and manufactures pharmaceuticals used to treat genetic diseases. This company is headquartered in Cambridge, Massachusetts.
Top C-suite Members of Company
Connect with key decision-makers at Sarepta Therapeutics. View contact details of C-suite executives and leadership team.
| Name | Title | Contact | |
|---|---|---|---|
| Douglas Ingram | Chief Executive Officer | d****m@sarepta.com | |
| Diane Berry | Global Health Policy Vice President | d****y@sarepta.com | |
| Ian Estepan | Executive VP | i****n@sarepta.com | |
| Nixon Luc | Sciences Director | n****c@sarepta.com | |
| Kirsten Meisterling | Senior Director | k****g@sarepta.com | |
| Cris Rothfuss | Executive VP | c****s@sarepta.com | |
| Alison Nasisi | Vice President | a****i@sarepta.com | |
| Django Andrews | Executive Director | d****s@sarepta.com | |
| Ryan Brown | General Counsel | r****n@sarepta.com | |
| Katrina Cahill | Head Vice President | k****l@sarepta.com | |
| Charles Gerrits | Global Senior VP | c****s@sarepta.com | |
| Peter O'Hanley | Senior VP | p****y@sarepta.com | |
| Ian Estepan | Executive VP | i****n@sarepta.com | |
| Cris Rothfuss | Executive VP | c****s@sarepta.com | |
| Cristin Rothfuss | Senior Vice President | c****s@sarepta.com | |
| Kirsten Meisterling | Senior Director | k****g@sarepta.com |
Email Formats
Discover the email patterns used at Sarepta Therapeutics to connect with the right people.
| Email Format | Example | Percentage |
|---|---|---|
| firstname.lastname@company.com | john.doe@company.com | 45% |
| firstname@company.com | john@company.com | 30% |
| firstinitial.lastname@company.com | j.doe@company.com | 15% |
| firstname_lastname@company.com | john_doe@company.com | 10% |
View Email formats of the company.
Email Verification Tool
Get verified email addresses of any IBM employee. Enjoy 100 free lookups every month.
Enter a person's name or an email address to verify
Technology Stack
Frequently Asked Questions
What is the address of Sarepta Therapeutics's headquarters?
Sarepta Therapeutics is headquartered at 215 First Street, Cambridge, Massachusetts 02142, USA.
How can I contact Sarepta Therapeutics by phone?
You can reach Sarepta Therapeutics by calling their customer support number at 6172744000.
Which stock symbol does Sarepta Therapeutics trade under?
The stock ticker for Sarepta Therapeutics is SRPT.
What is the official website for Sarepta Therapeutics?
You can visit Sarepta Therapeutics's official website at www.sarepta.com.
How much revenue does Sarepta Therapeutics generate?
Sarepta Therapeutics reports an annual revenue of approximately 1.25 Billion USD.
What is the SIC code for Sarepta Therapeutics?
The Standard Industrial Classification (SIC) code for Sarepta Therapeutics is 28,283.
What is the NAICS code for Sarepta Therapeutics?
Sarepta Therapeutics falls under the NAICS code 32,325.
How many people work at Sarepta Therapeutics?
Sarepta Therapeutics has a workforce of about 1700 employees.
Which technologies are used by Sarepta Therapeutics?
Sarepta Therapeutics utilizes technologies like PWA, Open Graph, Google Analytics.
Who is the Chief Executive Officer (CEO) of Sarepta Therapeutics?
The CEO of Sarepta Therapeutics is Douglas S. Ingram.
How can I get in touch with Sarepta Therapeutics?
To contact Sarepta Therapeutics, call 6172744000 or visit their website at www.sarepta.com
Is Sarepta Therapeutics a publicly traded company?
Yes, Sarepta Therapeutics is publicly listed and trades under the stock symbol SRPT.
How much total funding has Sarepta Therapeutics secured so far?
To date, Sarepta Therapeutics has raised $2.8B across 17 funding round(s).
Which industry is Sarepta Therapeutics part of?
Sarepta Therapeutics operates in the Pharmaceuticals, Healthcare industry.
Who are the main competitors of Sarepta Therapeutics?
Key competitors of Sarepta Therapeutics include Alnylam Pharmaceuticals, Ultragenyx, Ionis Pharmaceuticals, BioMarin
Which companies has Sarepta Therapeutics acquired?
Acquisitions by Sarepta Therapeutics include Ercole Biotech, Myonexus Therapeutics .
Who holds the CFO position at Sarepta Therapeutics?
Ian Estepan serves as the Chief Financial Officer (CFO) at Sarepta Therapeutics.
When did Sarepta Therapeutics complete its most recent funding round?
Sarepta Therapeutics latest funding round closed on Dec 13, 2019 with the amount of $250 Million
Who are the investors in Sarepta Therapeutics?
Sarepta Therapeutics is backed by 19 investors : CureDuchenne, Undisclosed, Undisclosed and Undisclosed.